Photonic Pharma LLC
Minneapolis, MN
- UEI
- GKPTJLFBHYX7
- CAGE
- 7C3P9
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 4744 Thomas Ave S, Minneapolis, MN 55410, USA
- Website
- photonicpharma.com
- Founded
- 2014
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Regents Of The University Of Minnesota | R01CA255513 | $1,101,861 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Jillion Therapeutics Inc. | NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Bellbrook Labs LLC | Madison, WI | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Potentiometric Probes LLC | Farmington, CT | — |
| Amydis, Inc. | San Diego, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Larix Bioscience LLC | Sunnyvale, CA | — |
About the company
Photonic Pharma LLC is a biotechnology research company that specializes in lead discovery for early-phase drug development. They utilize a groundbreaking technology platform combining fluorescence biosensor engineering and fluorescence lifetime detection for high-throughput screening of small molecule drug candidates.
Over the past few years, Photonic Pharma LLC has been awarded several federal grants totaling over $2.7 million from the National Institutes of Health (NIH) to develop innovative drug discovery platforms. A $612,942 grant from the NIH National Heart Lung and Blood Institute supported creating a high-throughput screening platform to identify compounds modulating cardiac myosin-binding protein C interactions for treating heart failure. Another $1.5 million grant from the NIH National Institute on Aging funded a pipeline targeting pathologically leaky ryanodine receptor calcium release channels implicated in Alzheimer's disease and age-related neurodegeneration. Photonic Pharma LLC has collaborated with academic partners like the University of Arizona, University of Minnesota, Rosalind Franklin University, and Loyola University Chicago on these NIH-funded projects. Their work spans therapeutic areas like cardiovascular disease, Alzheimer's, and neurodegenerative disorders, applying their core fluorescence biosensor and lifetime detection technologies to accelerate early-stage drug discovery.
Quick answers
Is Photonic Pharma LLC registered in SAM.gov?
Yes. Photonic Pharma LLC's SAM.gov registration is active through April 15, 2027.
What is Photonic Pharma LLC's most recent federal award?
Photonic Pharma LLC's most recent federal grant award is High-throughput discovery platform for modulators of cardiac muscle proteins to treat heart failure (R43HL162329), from National Heart Lung and Blood Institute (NIH), on April 15, 2022.
On GovTribe
See Photonic Pharma LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors